| ²é¿´: 294 | »Ø¸´: 1 | |||
TAINSTÌú³æ (ÕýʽдÊÖ)
|
[½»Á÷]
µÈÎÂ΢Á¿ÈÈ·¨¶Ô¹Ì̬ҩÎïµÄ±íÕ÷ ÒÑÓÐ1È˲ÎÓë
|
| Drug product development and manufacture requires numerous studies to ensure that the purity, quality, stability and safety of the product are characterized and well understood. A large percentage of drugs are formulated as solids. Since a given pharmaceutical chemical entity can often exist in more than one thermodynamically or kinetically stable crystal form, and often can also exist as a glass (amorphous state), it is important to characterize the properties of the crystalline and amorphous states and the factors affecting their interconversion. The ability of a compound to exist in these different solid state forms is known as polymorphism. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : µÈÎÂ΢Á¿ÈÈ·¨¶Ô¹Ì̬ҩÎïµÄ±íÕ÷.pdf
2016-06-20 14:23:51, 721.47 K
» ²ÂÄãϲ»¶
287Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
22408 344·Ö Çóµ÷¼Á Ò»Ö¾Ô¸ »ªµç¼ÆËã»ú¼¼Êõ
ÒѾÓÐ3È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
317Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
¹ãÎ÷´óѧ¼ÒÇÝÒÅ´«ÓýÖÖ¿ÎÌâ×é2026Äê˶ʿÕÐÉú£¨½ÓÊÕ¼ÆËã»úרҵµ÷¼Á£©
ÒѾÓÐ3È˻ظ´
ѧУÒѾÌá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂð£¿
ÒѾÓÐ8È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ5È˻ظ´
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ25È˻ظ´
085600²ÄÁÏÓ뻯¹¤
ÒѾÓÐ6È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
gwmgyp
°æÖ÷ (ÖªÃû×÷¼Ò)
°áש½«
- Ó¦Öú: 820 (²©ºó)
- ¹ó±ö: 3.006
- ½ð±Ò: 17161.9
- É¢½ð: 13
- ºì»¨: 67
- ɳ·¢: 1
- Ìû×Ó: 5612
- ÔÚÏß: 944.5Сʱ
- ³æºÅ: 1272275
- ×¢²á: 2011-04-21
- רҵ: Ò©Îï·ÖÎö
- ¹ÜϽ: ÐÂÒ©Ñз¢

2Â¥2016-06-25 09:32:08













»Ø¸´´ËÂ¥
·Ç³£¸Ðл·ÖÏí£¬Ï£ÍûÒÔºóÓиü¶àµÄ½»Á÷£¡